Clinical Trial Update: Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage - Pilot Study [Phase 4]

View source ↗

Summary

A phase 4 trial evaluating seizure prophylaxis with levetiracetam in aneurysmal subarachnoid hemorrhage has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seizures
• Subarachnoid Hemorrhage

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Subarachnoid Hemorrhage, Seizures | Phase 4 | Status: WITHDRAWN